Andera Partners
Gilles joined Andera Partners in 2002.
During his thirteen years in the biotechnology and pharmaceutical industries, Gilles held positions in the major industry segments: discovery, product development, clinical development, manufacturing, marketing, sales and business development.
He has extensive experience in negotiations, management of alliances and comprehensive operational management experience on a worldwide basis (Europe, US, Japan, Latin America).
He sits on several boards including GenKyoTex, Complix, Inotrem, Complexa and Crescendo Biologics. He was also a board member of U3 Pharma, Covagen and Glycovaxyn until their acquisition by large pharmaceutical companies.
Gilles graduated from Institut d’Etudes Politiques de Paris in 1980, received a Master’s in Applied Economics in 1982 and followed further business training at the Stanford Graduate School of Business.
This person is not in any offices
Andera Partners
ANDERA PARTNERS, was created in 2001 and is a leader in investments in unlisted companies in France and internationally. It manages over €2 billion in investments in life sciences (BioDiscovery), growth capital and OBO (Winch Capital for midcap and Cabestan Capital for small-cap) and sponsorless mezzanine debt.